Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Maitreya Medicare's EV-to-EBIT or its related term are showing as below:
NSE:MAITREYA's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 15.905 * Ranked among companies with meaningful EV-to-EBIT only.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Maitreya Medicare's Enterprise Value for the quarter that ended in Sep. 2023 was ₹0.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maitreya Medicare's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹39.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitreya Medicare EV-to-EBIT Related Terms
Maitreya Medicare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Maitreya Medicare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitreya Medicare EV-to-EBIT Chart
Maitreya Medicare Annual Data
Trend
Mar21
Mar22
Mar23
EV-to-EBIT
0.00
0.00
0.00
Maitreya Medicare Semi-Annual Data
Mar21
Mar22
Mar23
Sep23
EV-to-EBIT
0.00
0.00
0.00
0.00
NSE:MAITREYA vs HCA, DVA, THC: EV-to-EBIT Comparison
For the Medical Care Facilities subindustry, Maitreya Medicare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maitreya Medicare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maitreya Medicare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Maitreya Medicare's EV-to-EBIT falls into.
Maitreya Medicare's current Enterprise Value is ₹1,556.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maitreya Medicare's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹39.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitreya Medicare (NSE:MAITREYA) has a EV-to-EBIT of 39.61 as of Aug. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Maitreya Medicare and its competitors.
Is Maitreya Medicare's EV-to-EBIT too high?
Maitreya Medicare's current EV-to-EBIT is 39.61. The Healthcare Providers & Services industry median EV-to-EBIT is 15.91. Maitreya Medicare's value of 39.61 is 149% above this industry median. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's EV-to-EBIT compare to HCA and DVA?
Maitreya Medicare's EV-to-EBIT of 39.61 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBIT is 15.91. Maitreya Medicare's value of 39.61 is 149% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.91, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maitreya Medicare's current EV-to-EBIT of 39.61 is 149% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Maitreya Medicare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maitreya Medicare's current EV-to-EBIT is 39.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current EV-to-EBIT of 39.61. The current EV-to-EBIT is 39.61 and 149% above the Healthcare Providers & Services industry median of 15.91. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current EV-to-EBIT is 39.61 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score
Get the complete analysis for NSE:MAITREYA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAITREYA has been successfully added to your 
